» Articles » PMID: 39867867

Integrated Microbiome and Metabolome Analysis Reveals Correlations Between Gut Microbiota Components and Metabolic Profiles in Mice With Mitoxantrone-Induced Cardiotoxicity

Overview
Date 2025 Jan 27
PMID 39867867
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Mitoxantrone (MTX) is largely restricted in clinical usage due to its significant cardiotoxicity. Multiple studies have shown that an imbalance in the gut-heart axis plays an important role in the development of cardiovascular disease (CVD). We aim to explore the possible correlations between gut microbiota (GM) compositions and cardiometabolic (CM) disorder in MTX-triggered cardiotoxicity mice.

Methods: MTX cumulative dose of 6 mg/kg was administered to healthy Kunming male mice to trigger cardiotoxicity, with 1 mg/kg twice weekly for a duration of 3 weeks. Plasma CK-MB and LDH levels were determined, and the heart tissue histopathology was assessed, followed by utilizing an integrated liquid chromatography-mass spectrometry (LC-MS)-based heart metabolomics study alongside the 16S ribosomal RNA (rRNA) sequencing method to assess MTX impact on GM and CM profiles in mice, establishing associations between GM and CM profiles through the Pearson correlation coefficient calculation.

Results: MTX caused CK-MB and LDH level elevations and cardiotoxicity in our mouse model. MTX primarily affected the processes of protein digestion and absorption, mineral absorption, membrane transport, production of aminoacyl-transfer RNA (tRNA), metabolism of nucleotides, lipids, and amino acids, as well as autophagy. Additionally, MTX increased , and abundances and lowered , and abundances. The correlation analyses showcased variations in the abundance of diverse flora, such as _, which were related to MTX-induced cardiac injury.

Conclusion: Our study supports the claim that MTX provokes cardiotoxicity by modifying CM and GM profiles. Our results offer new possibilities for controlling MTX-triggered cardiotoxicity.

References
1.
Shirouchi B, Fukuda A, Akasaka T . Unlike Glycerophosphocholine or Choline Chloride, Dietary Phosphatidylcholine Does Not Increase Plasma Trimethylamine--Oxide Levels in Sprague-Dawley Rats. Metabolites. 2022; 12(1). PMC: 8779457. DOI: 10.3390/metabo12010064. View

2.
Bu Y, Xu J, Luo Q, Chen M, Mu L, Lu W . A Precise Nanostructure of Folate-Overhung Mitoxantrone DNA Tetrahedron for Targeted Capture Leukemia. Nanomaterials (Basel). 2020; 10(5). PMC: 7279534. DOI: 10.3390/nano10050951. View

3.
Fox E . Mechanism of action of mitoxantrone. Neurology. 2004; 63(12 Suppl 6):S15-8. DOI: 10.1212/wnl.63.12_suppl_6.s15. View

4.
Costa V, Capela J, Sousa J, Eleuterio R, Rodrigues P, Dores-Sousa J . Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations. Arch Toxicol. 2020; 94(12):4067-4084. DOI: 10.1007/s00204-020-02874-4. View

5.
Thomas X, Le Q, Fiere D . Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia. Ann Hematol. 2002; 81(9):504-7. DOI: 10.1007/s00277-002-0534-8. View